MicroPort CardioFlow Medtech Corp. (HK:2160) has released an update.
MicroPort CardioFlow Medtech Corporation announced the successful approval of all proposed resolutions during its Extraordinary General Meeting held on September 20, 2024. Shareholders voted in favor of the Equity Transfer Agreement and related authorizations, with over 83% of votes supporting the measures. This indicates a strong shareholder consensus on the company’s strategic decisions.
For further insights into HK:2160 stock, check out TipRanks’ Stock Analysis page.
